Repurposing pharmaceutical excipients as an antiviral agent against SARS-CoV-2

Author:

Malani Manisha1ORCID,Salunke Prerana1,Kulkarni Shraddha1,Jain Gaurav K.2,Sheikh Afsana3,Kesharwani Prashant3ORCID,Nirmal Jayabalan1ORCID

Affiliation:

1. Translational Pharmaceutics Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science (BITS)-Pilani, Hyderabad, India;

2. Department of Pharmaceutics, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, India;

3. Department of Pharmaceutics, School of Pharmaceutical Education and Research, New Delhi, India

Publisher

Informa UK Limited

Subject

Biomedical Engineering,Biomaterials,Bioengineering,Biophysics

Reference181 articles.

1. World Health Organization. Coronavirus disease 2019 (COVID-19), Situation Report – 117. 2020. Geneva, Switzerland.

2. Coronavirus Infections—More Than Just the Common Cold

3. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

4. World Health Organization. Coronavirus. 2020. Available from: https://www.who.int/health-topics/coronavirus#tab=tab_1

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3